EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Symptomatic Improvement in Amyotrophic Lateral Sclerosis During Low-Dose Sublingual Ketamine Treatment for Depression

Mitchell B. Liester, Bertrand Liang

Journal of Neurology Research · 2026-12 · 16 (4) · 288-298

DOI: 10.14740/jnr1140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurology Research, 2026-12. Verfasst von Mitchell B. Liester und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Liester, M. B., & Liang, B. (2026). Symptomatic Improvement in Amyotrophic Lateral Sclerosis During Low-Dose Sublingual Ketamine Treatment for Depression. Journal of Neurology Research, 16(4), 288-298. https://doi.org/10.14740/jnr1140

Vancouver

Liester MB, Liang B. Symptomatic Improvement in Amyotrophic Lateral Sclerosis During Low-Dose Sublingual Ketamine Treatment for Depression. Journal of Neurology Research. 2026;16(4):288-298. doi:10.14740/jnr1140

BibTeX
@article{Liester2026,
  author = {Liester, Mitchell B. and Liang, Bertrand},
  title = {Symptomatic Improvement in Amyotrophic Lateral Sclerosis During Low-Dose Sublingual Ketamine Treatment for Depression},
  journal = {Journal of Neurology Research},
  year = {2026},
  volume = {16},
  number = {4},
  pages = {288--298},
  doi = {10.14740/jnr1140}
}
Kostenlos starten →